Premium Essay

Dissemeniated Intravascular Coagulation

In:

Submitted By brookrn
Words 762
Pages 4
CELLULAR AND IMMUNE CONCEPTS

MARISA FRITKIN
MED 3015A
VICKI SWEET, INSTRUCTOR
OCTOBER 22, 2012

I decided to write my paper about the coagulation system, including clot formation, but mainly about Disseminated Intravascular Coagulation. Disseminated Intravascular Coagulation, also known as DIC, is a pathological activation of blood clotting mechanisms that may happen in response to a variety of diseases, or illnesses. However, DIC, is most commonly observed in severe sepsis and septic shock. DIC is not a specific illness, rather it is a complication or an effect of the progression of other illnesses or diseases. (Porth, 2011). When the body becomes injured, certain proteins in your blood become activated and travel to the injury site to help stop bleeding and control hemostasis. Hemostasis is the normal process of sealing off a blood vessel to prevent blood loss and hemorrhage. It is abnormal when it fails to appropriately clot the blood, or when this clotting is insufficient to stop the bleeding. Following an injury, there is an immediate vessel spasm that promotes vasoconstriction, which tries to diminish the blood flow. Collagen from the damaged site, releases platelets which adhere to the damaged vessel, and there, they undergo degranulation and release cytoplasmic granules, ADP, Thromboxane A2, and Serotonin which is a vasoconstrictor. The ADP then attracts more platelets to the area, and the Thromboxane A2 promotes platelet aggregation, degranulation, and even more vasoconstriction. This process promotes the formation of a platelet plug. The damaged tissue now releases Factor III (3), which, with the aid of Ca++, will activate Factor VII (7), which initiates the extrinsic mechanism of clotting. Factor XII (12), which comes from active platelets, will activate Factor XI (11), which initiates the intrinsic mechanism. Both active Factors VII

Similar Documents

Free Essay

Clinical Case of an Isolated Development Hypofibrinogenaemia

...Змачинский В.А., Цвирко Д.Г., Климов И.Н., Оводок А.Е. Клинический случай развития изолированной гипофибриногенемии на фоне лимфобластной клональной пролиферации На сегодняшний день опубликован ряд сообщений о нарушении гемокоагуляции у пациентов с различными формами лейкоза. У пациентов с острым лимфобластным лейкозом (ОЛЛ) коагулопатия наиболее часто проявляется на фоне лечения L-аспаргиназой [1]. Другие наиболее частые причины гипофибриногенемии – коагулопатия потребления и токсическое повреждение печени, снижающее белково-синтетическую функцию [2, 3]. Мы представляем клинический случай гипофибриногенемии на фоне дебюта ОЛЛ L2 по Франко-Америко-Британской классификации (FAB) без нарушения функции печени, наличия ДВС-синдрома и применения L-аспаргиназы на предшествующих этапах терапии. Фибриноген представляет собой гликопротеин с молекулярной массой 340-KD, который синтезируется в печени. Уровень фибриногена ниже 1,0 г/л недостаточен для поддержания гемостаза и может сопровождаться тяжелыми кровотечениями [4, 5]. Чаще в клинической практике встречаются приобретенные гипофибриногенемии, обусловленные острыми или хроническими заболеваниями печени [3]. У онкогематологических пациентов причиной гипофибриногенемии нередко бывает развитие ДВС крови [6, 7]. Наследственная гипофибриногенемия встречается редко. С момента опубликования первого доклада о наследственной гипофибриногенемии в 1935 году, было зарегистрированы всего 40 случаев и все они клинически проявлялись в раннем...

Words: 1350 - Pages: 6

Premium Essay

Nursing

...Risk for bleeding related to Disseminated Intravascular Coagulation as manifested by presence of petechiae and sudden bruising Cues | Nursing Diagnosis | Planning | Intervention | Rationale | Evaluation | Subjective:Objective:(+)Petechiae(+)sudden bruising | Risk for bleeding related to disseminated intravascular coagulation as manifested by presence of petechiae and sudden bruising | STG:After 2 hours of nursing intervention, the patient will be able to receive alert about the existing risk factors for bleeding. | Independent: * Established rapport * Monitored Vital signs * Maintained the patency of vascular access * Noted client to report of pain in specific areas, whether pain is increased, diffuse or localized * Examined dressings, draining tubes and collection canisters * Informed the patient the use of medications that increases bleeding or prolong clotting such as heparin, warfarin, aspirin etc. * Discussed the patterns of risk management to promote a lifestyle that focuses on injury avoidanceCollaborative: * Monitored diagnostic laboratories and administered blood transfusion, FFP or platelets as ordered by the physician; monitor for any transfusion reactions or drops in vital signs * If heparin therapy is initiated, observed for any increase in bleeding, purpura, petechiae or hematoma * Administered oxygen therapy | * To gain the patient’s trust * To obtain baseline data needed for early intervention * For fluid administration or blood...

Words: 285 - Pages: 2

Free Essay

Ocn Blueprint

...Test Blueprint I. Health Promotion and Disease Prevention – 5% of test content A. Epidemiology (e.g., at-risk populations including cultures; socioeconomic status; age; occupations) B. Prevention (e.g., high risk behaviors; preventive health practices) II. Screening, Early Detection and Diagnosis – 7% of test content C. Risk factors for cancer D. Screening E. Early detection F. Risk Reduction Guidelines G. Diagnostic testing III. Scientific Basis for Practice including Research – 10% of test content H. Carcinogenesis I. Immunology J. Genetics K. Specific cancers (pathophysiology, diagnostic measures, prognosis) L. Classification (tumors, staging, grading) M. Common metastatic sites N. Research Protocols and Clinical Trials IV. Cancer Treatment Modalities – 15% of test content O. Vascular access devices P. Surgery Q. Radiation R. Targeted therapies S. Biotherapy T. Chemotherapy U. Hematopoietic stem cell transplant V. Complementary, alternative and integrative modalities V. Symptom Management – 22% of test content (risk factors, prevention, education, management, and palliative care using the nursing process) W. Etiology and patterns of symptoms (acute, chronic, late) X. Toxicity and rating scales Y. Alterations in comfort Z. Alterations in protective mechanisms [. Alterations...

Words: 526 - Pages: 3